BHVN•benzinga•
Reported Earlier, Biohaven's Troriluzole NDA For Rare Disease SCA Receives Three-Month PDUFA Extension For Full FDA Review
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 15, 2025 by benzinga